-
Delafloxacin sold
under the
brand name
Baxdela (by
Melinta Therapeutics)
among others, is a
fluoroquinolone antibiotic used to
treat acute bacterial skin...
- (5th generation)
Ceftaroline (5th generation)
Clindamycin Dalbavancin Delafloxacin Fusidic acid
Mupirocin (topical)
Omadacycline Oritavancin Tedizolid Telavancin...
- antibiotics. It was
renamed Melinta Therapeutics in 2013. One of its products,
delafloxacin (BAXDELA®), a
fluoroquinolone antibiotic acquired from
Wakunaga Pharmaceutical...
-
clinafloxacin gatifloxacin moxifloxacin sitafloxacin prulifloxacin besifloxacin delafloxacin Two
structurally related fourth-generation drugs, but
formally not 4-quinolones...
-
degarelix (INN)
dehydrocholic acid (INN)
dehydroemetine (INN) Del-Vi-A
delafloxacin (USAN, INN)
Delalutin delamanid (USAN)
delandistrogene moxeparvovec (USAN...
-
combination (cell wall
synthesis inhibitor). FDA
approved on 29
August 2017.
Delafloxacin:
quinolone (inhibitor of DNA synthesis). FDA
approved on 19 June 2017...
- Sparfloxacin‡ Temafloxacin‡ Tosufloxacin‡ 4th
generation Besifloxacin Delafloxacin Gatifloxacin Finafloxacin Gemifloxacin Moxifloxacin# Clinafloxacin† Garenoxacin‡...
- J01MA19
Garenoxacin J01MA21
Sitafloxacin J01MA22
Tosufloxacin J01MA23
Delafloxacin J01MA24
Levonadifloxacin J01MA25
Lascufloxacin QJ01MA90 Enrofloxacin...
-
updated the
public on
eight new-generation fluoroquinolones: moxifloxacin,
delafloxacin, ciprofloxacin,
ciprofloxacin extended-release, gemifloxacin, levofloxacin...
-
pharmacokinetics of
novel quinolone agents represented by avarofloxacin,
delafloxacin, finafloxacin,
zabofloxacin and nemonoxacin".
Annals of
Clinical Microbiology...
